OMECS is an innovative division of CTSV s.r.l. with a focus on skincare innovation and development. Founded in 2019 and headquartered in Italy, the company is dedicated to developing brand new solutions in cosmeceutical and medical fields to improve dermal health. OMECS recently secured a €350.00K debt financing investment on 05 February 2020, marking a significant milestone for the company as it continues its mission to drive advancements in skincare. The company's commitment to pioneering innovations in the skincare industry positions it as a promising venture for potential investors seeking opportunities in the cosmeceutical and medical sectors.
General Information
Get notified when Omecs Cosmetics&Surgery moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Omecs Cosmetics&Surgery
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Italy Market
Food and Beverage
About Omecs Cosmetics&Surgery
Taxonomy: Skincare innovation, Cosmeceutical products, Medical skincare products, Dermal health solutions, Italian skincare, Snail slime skincare, Saffron skincare, Olive oil skincare, Clinical skincare products, Wound care products, Certified medical products, Regenerative skincare, Luxury anti-aging cosmetics, Innovative skincare techniques, Natural skincare ingredients
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | •••••• | - | 05 Feb 2020 |
Omecs Cosmetics&Surgery Alternatives & Competitors
Truth Treatment Systems™ is pharmacist-formulated medicinally potent skin care
Empowering dermatology with science-driven, premium skincare solutions
Advancing patient care with quality skincare brands
FAQ About Omecs Cosmetics&Surgery
Don't just browse. Track.
Signal Tracker monitors Omecs Cosmetics&Surgery and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.